Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells

被引:50
作者
Martin, G
Pilon, A
Albert, C
Vallé, M
Hum, DW
Fruchart, JC
Najib, J
Clavey, V
Staels, B
机构
[1] Inst Pasteur, Dept Atherosclerose, INSERM, U325, F-59019 Lille, France
[2] Univ Lille 2, Fac Pharm, F-59800 Lille, France
[3] Univ Laval, Ctr Hosp, Mol Endocrinol Lab, Laurier, PQ, Canada
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1999年 / 261卷 / 02期
关键词
adrenal gland; cholesterol metabolism; lipoproteins; receptor; steroidogenesis;
D O I
10.1046/j.1432-1327.1999.00296.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In rodents, cholesterol for adrenal steroidogenesis is derived mainly from high-density lipoproteins (HDL) via the HDL receptor, scavenger receptor-BI (SR-BI). In humans cholesterol for steroidogenesis is considered to be derived from the low-density lipoprotein (LDL) receptor pathway, and the contribution of SR-BI to that is unknown. In the present study SR-BI expression and regulation by steroidogenic stimuli was analysed in human adrenocortical cells and compared with LDL receptor expression. In addition, the functional contribution of both receptors for cholesteryl ester delivery to human adrenocortical cells was compared. Northern blot and reverse transcription-PCR amplification and sequence analysis demonstrated the presence of SR-BI mRNA in foetal and adult human adrenal cortex. Furthermore, SR-BI mRNA was expressed to similar levels in human primary adrenocortical and adrenocortical carcinoma NCI-H295 cells, indicating its presence in the steroid-producing cells. Treatment of NCI-H295 cells with 8Br-cAMP, a stimulator of glucocorticoid synthesis via the protein kinase A second messenger signal transduction pathway, resulted in an increase of both SR-BI and LDL receptor mRNA levels in a time- and dose-dependent manner. The induction of SR-BI and LDL receptor by cAMP was independent of ongoing protein synthesis and occurred at the transcriptional level. Ligand blot experiments indicated that a protein of similar size to SR-BI is the major HDL-binding protein in NCI-H295 cells. Western blot analysis demonstrated that cAMP treatment increased the levels of LDL receptor and, to a lesser extent, SR-BI protein in NCI-H295 cells. Binding and uptake of cholesterol was quantitatively smaller from HDL than from LDL, both in basal as well as in cAMP-stimulated cells. Scatchard analysis under basal conditions indicated that NCI-H295 cells express twice as many specific binding sites for LDL than for HDL. Dissociation constant values (K-d; in nM) were approximately five times higher for HDL than for LDL, indicating a lower affinity of HDL compared with LDL. The combined effects of these two parameters and the low cholesteryl ester content of HDL subfraction 3 (HDL3) contributes to a lower cholesteryl ester uptake from HDL than from LDL by the NCI-H295 cells. In conclusion, both the SR-BI and LDL receptor genes are expressed in the human adrenal cortex and coordinately regulated by activators of glucocorticoid synthesis. In contrast to rodents, in human adrenocortical cells the HDL pathway of cholesterol delivery appears to be of lesser importance than the LDL pathway. Nevertheless, the SR-BI pathway may become of major importance in conditions of functional defects in the LDL receptor pathway.
引用
收藏
页码:481 / 491
页数:11
相关论文
共 74 条
[11]  
BROWN MS, 1980, J BIOL CHEM, V255, P9344
[12]  
CALVO D, 1993, J BIOL CHEM, V268, P18929
[13]   CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins [J].
Calvo, D ;
GomezCoronado, D ;
Lasuncion, MA ;
Vega, MA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2341-2349
[14]   Structure and localization of the human gene encoding SR-BI/CLA-1 - Evidence for transcriptional control by steroidogenic factor 1 [J].
Cao, GP ;
Garcia, CK ;
Wyne, KL ;
Schultz, RA ;
Parker, KL ;
Hobbs, HH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :33068-33076
[15]   LIPOPROTEIN UTILIZATION AND CHOLESTEROL-SYNTHESIS BY THE HUMAN-FETAL ADRENAL-GLAND [J].
CARR, BR ;
SIMPSON, ER .
ENDOCRINE REVIEWS, 1981, 2 (03) :306-326
[16]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[17]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[18]   HUMAN CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME, P450SCC - CDNA CLONING, ASSIGNMENT OF THE GENE TO CHROMOSOME-15, AND EXPRESSION IN THE PLACENTA [J].
CHUNG, B ;
MATTESON, KJ ;
VOUTILAINEN, R ;
MOHANDAS, TK ;
MILLER, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) :8962-8966
[19]   STEROIDOGENIC FACTOR-I BINDING AND TRANSCRIPTIONAL ACTIVITY OF THE CHOLESTEROL SIDE-CHAIN CLEAVAGE PROMOTER IN RAT GRANULOSA-CELLS [J].
CLEMENS, JW ;
LALA, DS ;
PARKER, KL ;
RICHARDS, JS .
ENDOCRINOLOGY, 1994, 134 (03) :1499-1508
[20]  
CRAIG IF, 1982, J BIOL CHEM, V257, P330